Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro.

Slides:



Advertisements
Similar presentations
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Advertisements

The requirements and barriers to successful transition of adolescents with inflammatory bowel disease: Differing perceptions from a survey of adult and.
How do psychological variables influence coping strategies in inflammatory bowel disease?  Marta Iglesias-Rey, Manuel Barreiro-de Acosta, Francisco Caamaño-Isorna,
Serta Kılınçalp, Akif Altınbaş, Ömer Başar, Murat Deveci, Osman Yüksel 
Does the endoscopic appearance of the ileocecal valve suggest the severity of Crohn's disease in the terminal ileum?  Tamás Molnár, Klaudia Farkas, Ferenc.
Anti-tumor necrosis factor-α induced systemic lupus erythematosus in a patient with metastatic Crohn's disease—what is the role of anti-TNF antibody? 
Concurrent small bowel adenocarcinoma and carcinoid tumor in Crohn's disease — Case report and literature review  Doron Boltin, Zohar Levi, Marisa Halpern,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
YouTube® and inflammatory bowel disease
A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis  Urpo Kinnunen,
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Liver abscess of the caudate lobe due to Staphylococcus aureus in an ulcerative colitis patient: First case report  Andreia Albuquerque, Fernando Magro,
Ineffectiveness of infliximab therapy in severe infantile Crohn's disease  Nuray Uslu, Yusuf Usta, Inci Nur Saltik-Temizel, Hulya Demir, Figen Gürakan,
Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: The first case in the literature  Gurhan.
Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: A meta-analysis  Vincent Billioud, Alexander C. Ford,
High and increasing prevalence of inflammatory bowel disease in Finland with a clear North–South difference  Airi Jussila, Lauri J. Virta, Veikko Salomaa,
Prevalence of irritable bowel syndrome (IBS) in first-degree relatives of patients with inflammatory bowel disease (IBD)  Mariam Aguas, Vicente Garrigues,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
A. J. Walsh, M. Weltman, D. Burger, S. Vivekanandarajah, S. Connor, M
Anterior ischemic optic neuropathy in a patient with Crohn's disease and aberrant MTHFR and GPIIIa gene variants  T. Felekis, K.H. Katsanos, C.D. Zois,
The effects of anti-TNF-α treatment with adalimumab on growth in children with Crohn's disease (CD)  S. Malik, S.F. Ahmed, M.L. Wilson, N. Shah, S. Loganathan,
Serum prohepcidin levels in chronic inflammatory bowel diseases
Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever  Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,
Charlotte de Bie, Angelika Kindermann, Johanna Escher 
N. Kjaersgaard Nielsen, V. Wewer, L. Skafte, A. Paerregaard 
Hemophagocytic syndrome in a child with severe Crohn's disease and familial Mediterranean fever  Nuray Uslu, Hulya Demir, Gunay Balta, Inci N Saltik-Temizel,
Endothelial function and cardiovascular risk in active inflammatory bowel diseases  Mariabeatrice Principi, Mario Mastrolonardo, Pietro Scicchitano, Michele.
Fatal Colonic Perforation in a Pregnant with Behçet's Disease
Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease  Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim  Journal.
Familial aggregation in Crohn's disease and ulcerative colitis in a Norwegian population- based cohort followed for ten years  May-Bente Bengtson, Camilla.
Public awareness of Crohn's disease and ulcerative colitis: A national survey  Sieglinde Angelberger, Harald Vogelsang, Gottfried Novacek, Wolfgang Miehsler,
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
B. Sicilia, F. Arribas, J. Nerín, C. López Miguel, R. Vicente, F
Incidence of ulcerative colitis and Crohn's disease in Danish children: Still rising or levelling out?  Christian Jakobsen, Vibeke Wewer, Frederikke Urne,
Activated thrombin activatable fibrinolysis inhibitor (TAFIa) is associated with inflammatory markers in inflammatory bowel diseases  Danuta Owczarek,
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Gord Blackhouse, Nazila Assasi,
Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature  Dana Duricova, Johan Burisch,
Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: A systematic review and meta-analysis  Thomas W. Lee, Michael.
A case of pyoderma gangrenosum with ulcerative colitis treated with combined approach: Infliximab and surgery  G. Andrisani, L. Guidi, A. Papa, A.E. Potenza,
Role of Angiogenic and Inflammatory Signal Pathways in Psoriasis
Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment.
Paula Borralho, Ana Vieira, João Freitas, Paula Chaves, Jorge Soares 
Clinical trials in luminal Crohn's disease: A historical perspective
M. Chaparro, P. Martínez-Montiel, M. Van Domselaar, F. Bermejo, J. L
Xian-rui Wu, Saurabh Mukewar, Ravi P. Kiran, Feza H
The usefulness of factor XIII levels in Crohn's disease
Rapid improvement of refractory pyoderma gangrenosum with infliximab gel in a patient with ulcerative colitis  Niels Teich, Tobias Klugmann  Journal of.
Seth Lipka, Seymour Katz, Lev Ginzburg  Journal of Crohn's and Colitis 
Osteoporosis in inflammatory bowel disease
Fast and sharp decrease in calprotectin predicts remission by infliximab in anti-TNF naïve patients with ulcerative colitis  M. De Vos, O. Dewit, G. D'Haens,
Pediatric pulmonary Crohn's disease: More frequent than expected
Suppurative granulomatous inflammation in the ileo-anal pouch
Ulrich Bonse-Geuking, Michael Kraus  Journal of Crohn's and Colitis 
Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome 
Increase in bone mineral density in strictly treated Crohn's disease patients with concomitant calcium and vitamin D supplementation  Sjoerd F. Bakker,
Canadian cost-utility analysis of initiation and maintenance treatment with anti-TNF-α drugs for refractory Crohn's disease  Gord Blackhouse, Nazila Assasi,
A case report: Ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis  Urpo Kinnunen,
Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis  Brittany G. Craiglow, Brett A. King 
Yield and cost effectiveness of mycobacterial infection detection using a simple IGRA- based protocol in UK subjects with inflammatory bowel disease suitable.
Does active smoking really influence the course of Crohn's disease
Genotyping should be considered the primary choice for pre-treatment evaluation of thiopurine methyltransferase function  Ulf Hindorf, Malin Lindqvist.
Yinghong Wang, Hua Gong, Rocio Lopez, Lei Lian, Ravi P. Kiran, Edy E
Surgical management of gluteal metastatic cutaneous Crohn's disease
Complete remission of a primary rectal lymphoma on ulcerative colitis, after withdrawal of azathioprine and infliximab  Antonio López San Román, Manuel.
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis  S.D. McLaughlin, A. Culkin,
Bowel sonography in occlusive Crohn's disease
The role of in vitro interferonγ-release assay in differentiating intestinal tuberculosis from Crohn's disease in China  Yue Li, Li-fan Zhang, Xiao-qing.
Health-related quality of life in inflammatory bowel disease: Psychosocial, clinical, socioeconomic, and demographic predictors  Anilga Moradkhani, Linda.
Figure 1 Approximate timeline contrasting major historical events in the understanding of ulcerative colitis (red) and ... Figure 1 Approximate timeline.
Mechanisms of LtxA (Leukotoxin), a Potent New Anti-Inflammatory Agent for the Treatment of Alopecia Areata  Scott C. Kachlany  Journal of Investigative.
Presentation transcript:

Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease  Giammarco Mocci, Manuela Marzo, Alfredo Papa, Alessandro Armuzzi, Luisa Guidi  Journal of Crohn's and Colitis  Volume 7, Issue 10, Pages 769-779 (November 2013) DOI: 10.1016/j.crohns.2013.01.009 Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 1 Injection site reaction with the use of adalimumab. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 2 Psoriatic lesion under infliximab therapy: Chin. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 3 Psoriatic lesion under infliximab therapy: Ear lobe. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 4 Psoriatic lesion under infliximab therapy: Auricolar region. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 5 Psoriatic lesion under infliximab therapy: Scalp psoriasis with alopecia. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 6 Psoriatic lesion under infliximab therapy: Right arm. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 7 Psoriatic lesion under infliximab therapy: Ungual psoriasis. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Figure 8 Psoriatic lesion under infliximab therapy: Plantar psoriasis. Journal of Crohn's and Colitis 2013 7, 769-779DOI: (10.1016/j.crohns.2013.01.009) Copyright © 2013 European Crohn's and Colitis Organisation Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.